These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12795833)
1. [Antitumor effects of soluble TRAIL in human hepatocellular carcinoma]. He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhao YZ; Wang SF Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):116-9. PubMed ID: 12795833 [TBL] [Abstract][Full Text] [Related]
2. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma. Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma]. Zhu RX; Lin JS; Song YH; Li PY; Tao LW Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):261-4. PubMed ID: 16875623 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of soluble TRAIL in human hepatocellular carcinoma. He S; Chen Y; Chen X; Zhao Y; Wang H; Zhang W; Wang S J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):51-4. PubMed ID: 15934308 [TBL] [Abstract][Full Text] [Related]
5. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin]. He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357 [TBL] [Abstract][Full Text] [Related]
6. Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma. Chen XP; He SQ; Wang HP; Zhao YZ; Zhang WG World J Gastroenterol; 2003 Nov; 9(11):2433-40. PubMed ID: 14606071 [TBL] [Abstract][Full Text] [Related]
7. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. Koyama S; Koike N; Adachi S J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476 [TBL] [Abstract][Full Text] [Related]
8. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells. Yang JF; Cao JG; Tian L; Liu F Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448 [TBL] [Abstract][Full Text] [Related]
9. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619 [TBL] [Abstract][Full Text] [Related]
10. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study]. Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022 [TBL] [Abstract][Full Text] [Related]
11. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Yamanaka T; Shiraki K; Sugimoto K; Ito T; Fujikawa K; Ito M; Takase K; Moriyama M; Nakano T; Suzuki A Hepatology; 2000 Sep; 32(3):482-90. PubMed ID: 10960439 [TBL] [Abstract][Full Text] [Related]
13. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N; Poulaki V; Mitsiades C; Tsokos M Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419 [TBL] [Abstract][Full Text] [Related]
15. Expression and antitumor effects of TRAIL in human cholangiocarcinoma. Tanaka S; Sugimachi K; Shirabe K; Shimada M; Wands JR Hepatology; 2000 Sep; 32(3):523-7. PubMed ID: 10960444 [TBL] [Abstract][Full Text] [Related]
16. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma. Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718 [TBL] [Abstract][Full Text] [Related]
17. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931 [TBL] [Abstract][Full Text] [Related]
18. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma. Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278 [TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo. Fan QL; Zou WY; Song LH; Wei W Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]